AmSurg Financial Statements
AmSurg Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
AmSurg Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 600.7 | 531.1 | 464.6 |
| Gross Profit ($ mil.) | 356.4 | 205.6 | 180.5 |
| Operating Income ($ mil.) | 92.2 | 81.6 | 70.6 |
| Total Net Income ($ mil.) | 47.0 | 44.2 | 37.7 |
| Diluted EPS (Net Income) | 1.47 | 1.42 | 1.24 |
AmSurg Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 167.9 | 168.8 | 163.5 |
| Gross Profit ($ mil.) | 147.5 | 147.9 | 94.6 |
| Operating Income ($ mil.) | 56.8 | 58.4 | -- |
| Total Net Income ($ mil.) | 46.3 | 46.9 | 44.3 |
| Diluted EPS (Net Income) | 0.45 | 0.44 | 0.40 |
AmSurg Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.07 | 0.32 | 7.01 |
| Price/Earnings Ratio | 11.86 | 9.27 | 25.51 |
| Price/Book Ratio | 1.34 | 2.02 | 6.74 |
| Price/Cash Flow Ratio | 6.35 | 3.89 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed AmSurg Financial Ratios
AmSurg Competitive Intelligence
| NovaMed | Symbion | United Surgical Partners | |
|---|---|---|---|
| Annual Sales ($ mil.) | 141.2 | 331.9 | 642.2 |
| Employees | 810 | 2,600 | 6,300 |
| Market Cap ($ mil.) | 95.0 | -- | -- |
Competitive Landscape
